Top news of the week: 18.10.2022.
CRISPR pioneer Feng Zhang is building a secretive new startup to solve gene-editing's biggest problem — getting into more parts of the body
Backed by GV and Arch Venture Partners, the stealth startup Aera Therapeutics is trying to solve gene-editing's big delivery problem.
Triplet Therapeutics, biotech company focused on Huntington’s, quietly shuts down
Triplet Therapeutics, a biotech company co-founded by venture capital firm Atlas Venture, has shut down after running into problems with its lead drug and raising new funding.
Josh Bilenker’s last biotech sold for $8 billion. His next one is cloaked in mystery but loaded with money
The big fundraising effort by Josh Bilenker and Jeffrey Engelman is likely to seed even more curiosity about what, exactly, is happening at their new company, Treeline.
Without a nasal vaccine, the U.S. edge in fighting Covid is on the line
Foreign rivals are developing vaccines that could stop transmission before the U.S., and that’s a potential biosecurity threat.
The Search for a Pill That Can Help Dogs—and Humans—Live Longer
People have been searching for a fountain of youth for thousands of years. Celine Halioua thinks she’s found one—for canines. Be patient, we’re next.
Meet the 16 pioneering biotech VCs who are taking new approaches to investing and reshaping the industry's future
These 16 biotech investors are all in their first decade of working in venture capital and bringing fresh perspectives to the world of biotech.
Gene-editing companies are growing thanks to fast-paced science, even as biotech faces a downturn
Biotech startups specializing in gene editing aren't just surviving but thriving through a rocky stock market, driven by scientific and clinical wins.
Biotech Startup Surge Therapeutics Gathers $26 Million for Cancer Treatment
Cambridge, Mass.-based company is developing a treatment that might prolong the lives of cancer patients who require surgery to remove a tumor.